Boucher, Fabien
Eychenne, Catherine
Gurriet, Brice
Berreni, Nicolas
Berrocal, Juan
Foulc, Phryné
Levy, Alain
Guzman-Ruiz, Adriana
Hersant, Barbara
Funding for this research was provided by:
Laboratoires VIVACY
Article History
Received: 5 December 2024
Accepted: 6 February 2025
First Online: 3 March 2025
Declarations
:
: The study received French ethics committee approval on 06 September 2019 (Comité de Protection des Personnes EST-III, 19.09.02/SI, CNRIPH 19.05.02.61300, ID-RCB 2019-A01241-56) and was registered with ClinicalTrials.gov (, NCT 04147689).
: All authors were study investigators and had contracts with Laboratoires VIVACY either directly or through their institution for participation in the study (including fees for patient recruitment and follow-up, as well as provision of study products). FB was remunerated by Laboratoires VIVACY for coordinator activities in this study. FB, NB, JB, and BH received travel expenses and/or honoraria from Laboratoires VIVACY. CE was remunerated by Laboratoires VIVACY for acting as a consultant and by TEOXANE for participating in research.